March 23, 2004 — Eikos Inc. (Profile, News, Web), a Franklin, Mass.-based developer of transparent carbon nanotube inks for conductive coatings and circuits, is acquiring a 40 percent stake in a Connecticut firm formed to develop nanotube-based medical and security devices.
Groton, Conn.-based MysticMD gains the rights to Eikos’ Invisicon nanotube formulations for products in those areas, while Eikos focuses on organic light-emitting diodes, flexible solar cells and other markets. MysticMD founder Joel Douglas said in a written statement that the partnership will allow his company to get products to market faster.
Douglas, who also serves as MysticMD’s chief technology officer, co-founded Amira Medical Inc., which developed glucose monitoring products. Roche Diagnostics acquired Amira in 2001.